Document is current
Any future updates will be listed below
-
Authors
,
Mackin, Sharon T.
Nelson, Scott M.
Wild, Sarah H.
Colhoun, Helen M.
Wood, Rachael
Lindsay, Robert S.
-
Funding
Funding for this research was provided by:
Glasgow Children's Hospital Charity
- License Information
-
More Information
Article History
Received: 16 January 2019
Accepted: 20 May 2019
First Online: 29 July 2019
Duality of interest
: HMC has received research support and honoraria and is a member of advisory panels for Sanofi Aventis, Regneron, Novartis Pharmaceuticals, Novo-Nordisk and Eli Lilly. HMC has received research support from Pfizer and AstraZeneca LP and is a shareholder of Roche Pharmaceuticals and Bayer. RSL has acted on advisory boards for NovoNordisk, Eli Lilly and Servier. These authors have no conflict of interest in presentation of this manuscript. There are no conflicts of interest from the other authors.
